Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 12/2016

01.12.2016 | Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor)

Hepatic and Intra-abdominal Tuberculosis: 2016 Update

verfasst von: Richard P. T. Evans, Moustafa Mabrouk Mourad, Lee Dvorkin, Simon R. Bramhall

Erschienen in: Current Infectious Disease Reports | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Mycobacterium tuberculosis (TB) infection affects nearly 10 million people a year and causes 1.5 million deaths. TB is common in the immunosuppressed population with 12 % of all new diagnoses occurring in human immune deficiency virus (HIV)-positive patients. Extra-pulmonary TB occurs in 12 % of patients with active TB infection of which 3.5 % is hepatobiliary and 6–38 % is intra-abdominal. Hepatobiliary and intra-abdominal TB can present with a myriad of non-specific symptoms, and therefore, diagnosis requires a high level of suspicion. Accurate and rapid diagnosis requires a multidisciplinary team (MDT) approach using radiology, interventional radiology, surgery and pathology services. Treatment of TB is predominantly medical, yet surgery plays an important role in managing the complications of hepatobiliary and intra-abdominal TB.
Literatur
1.
World Health O. Global tuberculosis report. Geneva: World Health O; 2015.
2.
American Thoracic S. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376–95.CrossRef
3.
Naing C, Mak JW, Maung M, Wong SF, Kassim AIBM. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013;191(1):27–34.CrossRefPubMed
4.
Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199–205.CrossRefPubMed
5.
Amarapurkar DN, Patel ND, Amarapurkar AD. Hepatobiliary tuberculosis in western India. Indian J Pathol Microbiol. 2008;51(2):175.CrossRefPubMed
6.
Morris E. Tuberculosis of the liver. Am Rev Tuberc. 1930;22:585–92.
7.
8.
Essop AR, Posen JA, Hodkinson JH, Segal I. Tuberculosis hepatitis: a clinical review of 96 cases. Q J Med. 1984;53(4):465–77.PubMed
9.
Tai W-c, Kuo C-m, Lee C-h, Chuah S-k, Huang C-c, Hu T-h, et al. Liver tuberculosis in Southern Taiwan: 15-years clinical experience. Intern Med Chi. 2008;19:410–7.
10.
Hulnick DH, Megibow AJ, Naidich DP, Hilton Z, Cho KC, Balthazar EJ. Abdominal tuberculosis: CT evaluation. Radiology. 1985;157(1):199–204.CrossRefPubMed
11.
Alvarez SZ. Hepatobiliary tuberculosis. Phil J Gastroenterol. 2006;2:1–10.
12.
Mourad MM, Liossis C, Algarni A, Kumar S, Bramhall SR. Primary hepatic tuberculosis in immunocompetent adults: a UK case series. Oxf Med Case Rep. 2014;2014(9):148–50.CrossRef
13.
• Terry RB, Gunnar RM. Primary miliary tuberculosis of the liver. J Am Med Assoc. 1957;164(2):150–7. Important reference showed principles of clinical presentation and diagnosis of hepatic tuberculosis.CrossRefPubMed
14.
Hersch C. Tuberculosis of the liver. S Afr Med J. 1964;38:857.PubMed
15.
Ahmed M, Mugal MA, Maingal MA. Varied intestinal tuberculosis: an experience at Sandeman Hospital Quetta. J Coll Phys Surg Pak. 2000;10:246–8.12.
16.
Ooi JLS, Tai FWD, Wong S, Thaha MA, Potter JL, Coral White VL, et al. Diagnosis of abdominal tuberculosis in East London, UK. Eur Respir J. 2014;44 Suppl 58:P3052.
17.
•• Gilinsky NH, Marks IN, Kottler RE, Price SK. Abdominal tuberculosis. A 10-year review. S Afr Med J. 1983;64(22):849–57. Very important reference with cumultive data about abdominal TB.
18.
Burke KA, Patel A, Jayaratnam A, Thiruppathy K, Snooks SJ. Diagnosing abdominal tuberculosis in the acute abdomen. Int J Surg. 2014;12(5):494–9.CrossRefPubMed
19.
Mamo JP, Brij SO, Enoch DA. Abdominal tuberculosis: a retrospective review of cases presenting to a UK district hospital. Q J Med. 2013:hct003.
20.
Uzunkoy A, Harma M. Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol: WJG. 2004;10(24):3647–9.CrossRefPubMedPubMedCentral
21.
Saluja SS, Ray S, Pal S, Kukeraja M, Srivastava DN, Sahni P, et al. Hepatobiliary and pancreatic tuberculosis: a two decade experience. BMC Surg. 2007;7(1):1.CrossRef
22.
Tuberculosis. NICE guidelines [NG33] 2016.
23.
von Hahn T, Bange F-C, Westhaus S, Rifai K, Attia D, Manns M, et al. Ultrasound presentation of abdominal tuberculosis in a German tertiary care center. Scand J Gastroenterol. 2014;49(2):184–90.CrossRef
24.
Atzori S, Vidili G, Delitala G. Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis. J Infect Develop Countries. 2012;6(12):886–90.
25.
Goblirsch S, Bahlas S, Ahmed M, Brunetti E, Wallrauch C, Heller T. Ultrasound findings in cases of extrapulmonary TB in patients with HIV infection in Jeddah, Saudi Arabia. Asian Pac J Trop Dis. 2014;4(1):14–7.
26.
Malik A, Saxena NC. Ultrasound in abdominal tuberculosis. Abdom Imaging. 2003;28(4):0574–9.CrossRef
27.
Yang G, Zhang W, Yu T, Meng J, Zhao D, Zhang X, et al. The features of intestinal tuberculosis by contrast-enhanced ultrasound. Jpn J Radiol. 2015;33(9):577–84.CrossRefPubMed
28.
Kalra N, Agrawal P, Mittal V, Kochhar R, Gupta V, Nada R, et al. Spectrum of imaging findings on MDCT enterography in patients with small bowel tuberculosis. Clin Radiol. 2014;69(3):315–22.CrossRefPubMed
29.
30.
Zhao X-S, Wang Z-T, Wu Z-Y, Yin Q-H, Zhong J, Miao F, et al. Differentiation of Crohn’s disease from intestinal tuberculosis by clinical and CT enterographic models. Inflamm Bowel Dis. 2014;20(5):916–25.CrossRefPubMed
31.
Mao R, Liao WD, He Y, Ouyang CH, Zhu ZH, Yu C, et al. Computed tomographic enterography adds value to colonoscopy in differentiating Crohn’s disease from intestinal tuberculosis: a potential diagnostic algorithm. Endoscopy. 2015;47(4):322–9.CrossRefPubMed
32.
Tirumani SH, Ojili V, Gunabushanam G, Shanbhogue AKP, Nagar A, Fasih N, et al. Imaging of tuberculosis of the abdominal viscera: beyond the intestines. J Clin Imaging Sci. 2013;3(1):17.CrossRefPubMedPubMedCentral
33.
Karunanithi S, Sharma P, Jain TK, Vijay MK, Kumar R. Multiple hepatic lesions in a case of isolated hepatic tuberculosis simulating metastases on 18F-FDG PET/CT imaging. Nucl Med Rev. 2014;17(2):108–9.CrossRef
34.
Wang X, Shi X, Yi C, Chen Z, Zhang B, Zhang X. Hepatic tuberculosis mimics metastasis revealed by 18F-FDG PET/CT. Clin Nucl Med. 2014;39(6):e325–7.CrossRefPubMed
35.
Dong A, Wang Y, Gong J, Zuo C. FDG PET/CT findings of common bile duct tuberculosis. Clin Nucl Med. 2014;39(1):67–70.CrossRefPubMed
36.
Chatterjee S, Schmid ML, Anderson K, Oppong KW. Tuberculosis and the pancreas: a diagnostic challenge solved by endoscopic ultrasound. A case series. J Gastrointestin Liver Dis. 2012;21(1):105–7.PubMed
37.
Rana SS, Sharma V, Sharma R, Bhasin DK. Involvement of mediastinal/intra-abdominal lymph nodes, spleen, liver, and left adrenal in presumed isolated pancreatic tuberculosis: an endoscopic ultrasound study. J Digest Endosc. 2015;6(1):15.CrossRef
38.
Diehl DL, Johal AS, Shieh FK, Ramesh J, Varadarajulu S, Ali A, et al. Su1583 endoscopic ultrasound-guided liver biopsy: a multicenter experience. Gastrointest Endosc. 2013;77(5):AB375.
39.
40.
Visscher AP, Felt-Bersma RJF. Endoanal ultrasound in perianal fistulae and abscesses. Ultrasound Q. 2015;31(2):130–7.CrossRefPubMed
41.
Youssef AT. Imaging classification of perianal fistula using the ultrasound. J Gastroenterol Hepatol Res. 2015;4(6):1653–9.CrossRef
42.
Gan H, Mely M, Zhao J, Zhu L. An analysis of the clinical, endoscopic, and pathologic features of intestinal tuberculosis. J Clin Gastroenterol. 2016.
43.
Ibrarullah M, Mohan A, Sarkari A, Srinivas M, Mishra A, Sundar TS. Abdominal tuberculosis: diagnosis by laparoscopy and colonoscopy. Trop Gastroenterol. 2001;23(3):150–3.
44.
45.
Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol. 1993;88(7):989–99.PubMed
46.
Krishnan P, Othiyil Vayoth S, Dhar P, Surendran S, Ponnambathayil S. Laparoscopy in suspected abdominal tuberculosis is useful as an early diagnostic method. ANZ J Surg. 2008;78(11):987–9.CrossRefPubMed
47.
Islam J, Clarke D, Thomson SR, Wilson D, Dawood H. A prospective audit of the use of diagnostic laparoscopy to establish the diagnosis of abdominal tuberculosis. Surg Endosc. 2014;28(6):1895–901.CrossRefPubMed
48.
Singh R, Jain P, Saxena N. FNAC, lymphadenopathy, Mantoux test, tuberculosis, Ziehl-Neelsen stain. Diagnosis of tubercular lymphadenopathy by fine needle aspiration cytology, acid-fast staining and Mantoux test. 2015(5).
49.
World Health O. Implementing tuberculosis diagnostics: policy framework. 2015.
50.
Maharaj B, Leary WP, Pudifin DJ. A prospective study of hepatic tuberculosis in 41 black patients. Q J Med. 1987;63(3):517–22.PubMed
51.
Ramesh J, Banait GS, Ormerod LP. Abdominal tuberculosis in a district general hospital: a retrospective review of 86 cases. Q J Med. 2008;101(3):189–95.CrossRef
52.
Chang EW, Page A-L, Bonnet M. Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis. Eur Respir J. 2015:ERJ-00978-2015.
53.
Samant H, Desai D, Abraham P, Joshi A, Gupta T, Rodrigues C, et al. Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis in Mumbai, India. Indian J Gastroenterol. 2014;33(5):414–9.CrossRefPubMed
54.
• Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis. 2015;78(2):47–55. Imortant recent reference with updated treatment of extrapulmonary TB.CrossRef
55.
King TC, Upfal M, Gottlieb A, Adamo P, Bernacki E, Kadlecek CP, et al. T-SPOT. TB interferon-γ release assay performance in healthcare worker screening at nineteen US hospitals. Am J Respir Crit Care Med. 2015;192(3):367–73.CrossRefPubMed
56.
Lee YM, Park KH, Kim SM, Park SJ, Lee SO, Choi SH, et al. Risk factors for false-negative results of T-SPOT. TB and tuberculin skin test in extrapulmonary tuberculosis. Infection. 2013;41(6):1089–95.CrossRefPubMed
57.
Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, et al. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis–HIV burden setting. Am J Respir Crit Care Med. 2015;191(7):820–30.CrossRefPubMedPubMedCentral
58.
Turtle L, Kemp T, Davies GR, Squire SB, Beeching NJ, Beadsworth MBJ. In routine UK hospital practice T-SPOT. TB™ is useful in some patients with a modest pre-test probability of active tuberculosis. Eur J Intern Med. 2012;23(4):363–7.CrossRefPubMedPubMedCentral
59.
World Health O. Treatment of tuberculosis: guidelines. Geneva: World Health Organization; 2010.
60.
Critchley JA, Young F, Orton L, Garner P. Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):223–37.CrossRefPubMed
61.
Lai CC, Lee MT, Lee SH, Chang SS, Lee CC. Risk of incident active tuberculosis and use of corticosteroids. Int J Tuberc Lung Dis. 2015;19(8):936–42.CrossRefPubMed
62.
Lee C-H, Kim K, Hyun MK, Jang EJ, Lee NR, Yim J-J. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax. 2013:thoraxjnl-2012-203175.
63.
Hwang SW, Kim YJ, Cho EJ, Choi JK, Kim SH, Yoon J-H, et al. Clinical features of hepatic tuberculosis in biopsy-proven cases. Korean J Hepatol. 2009;15(2):159–67.CrossRefPubMed
64.
Gounder L, Drain PK, Hickey AJ, Moosa MYS. Hepatic tuberculosis: a retrospective case–control study in Durban, South Africa. Cape Town: Poster session presented at: Southern HIV Clinicians Society Conference; 2012.
65.
American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1–77.
66.
Pusch T, Pasipanodya JG, Hall RG, Gumbo T. Therapy duration and long-term outcomes in extra-pulmonary tuberculosis. BMC Infect Dis. 2014;14(1):1.CrossRef
67.
Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, et al. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS. 2014;28:S25–34.CrossRefPubMed
68.
Uthman OA, Okwundu C, Gbenga K, Volmink J, Dowdy D, Zumla A, et al. Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Ann Intern Med. 2015;163(1):32–9.CrossRefPubMed
69.
Dusthackeer A, Sekar G, Chidambaram S, Kumar V, Mehta P, Swaminathan S. Drug resistance among extrapulmonary TB patients: six years experience from a supranational reference laboratory. Indian J Med Res. 2015;142(5):568.CrossRefPubMedPubMedCentral
70.
Zemlyanaya N, Gelmanova I, Mishustin S, Janova G. Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia). Eur Respir J. 2015;46 suppl 59:A2703.CrossRef
71.
Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, et al. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med. 2014;2(4):321–38.CrossRefPubMed
72.
Lange C, Abubakar I, Alffenaar J-WC, Bothamley G, Caminero JA, Carvalho ACC, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44(1):23–63.CrossRefPubMedPubMedCentral
73.
Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66.CrossRefPubMed
74.
Cai Y, Yi J, Zhou C, Shen X. Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis. PLoS One. 2012;7(10):e47769.CrossRefPubMedPubMedCentral
75.
Wang PY, Xie SY, Hao Q, Zhang C, Jiang BF. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis [Review article]. Int J Tuberc Lung Dis. 2012;16(5):589–95.PubMed
76.
Zhang S, Pan H, Lu H, Fan H, Peng X, Zheng X, et al. Preventive use of a hepatoprotectant against anti‐tuberculosis drug‐induced liver injury: a randomized controlled trial. J Gastroenterol Hepatol. 2015.
77.
Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement Altern Med. 2015;15(1):1.CrossRef
78.
Gu J, Tang S-J, Tan S-Y, Wu Q, Zhang X, Liu C-X, et al. An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury. Int J Clin Exp Med. 2015;8(3):4320.PubMedPubMedCentral
79.
Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, et al. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol. 2010;22(10):1235–8.CrossRefPubMed
80.
Bhansali SK. Abdominal tuberculosis. Experiences with 300 cases. Am J Gastroenterol. 1977;67(4):324–37.PubMed
81.
Chalya PL, McHembe MD, Mshana SE, Rambau PF, Jaka H, Mabula JB. Clinicopathological profile and surgical treatment of abdominal tuberculosis: a single centre experience in northwestern Tanzania. BMC Infect Dis. 2013;13(1):270.CrossRefPubMedPubMedCentral
82.
Pattanayak S, Behuria S. Is abdominal tuberculosis a surgical problem? Ann R College Surg England. 2015;97(6):414–9.CrossRef
83.
Krishnanand RC, Chanchlani M, Mahawar P, Sinha U. A study of clinical presentation and management of abdominal tuberculosis in a tertiary care hospital. J Evol Med Dent Sci. 2013;46:8925–31.CrossRef
84.
Dandapat MC, Mohan Rao V. Management of abdominal tuberculosis. Ind J Tuberc. 1985;32:126–9.
85.
Sood R, Sethu Madhavan M. Diagnostic approach to abdominal tuberculosis. Clinical medicine: a practical manual for students and practitioners. India: Jaypee Brothers Medical Publishers (P) Ltd; 2007. p. 249.
86.
87.
Ghoneim I, Zuhdi Z, Arrifin AC, Othman H, Jarmin R, Azman A. Mistaking primary hepatic tuberculosis for malignancy: could surgery have been avoided? Formosan J Surg. 2015;48(3):94–7.CrossRef
88.
Hanafiah M, Alhabshi SMI, Bag T, Low SF. Probable hepatic tuberculosis masquerading as Klatskin tumour in an immunocompetent patient. BMJ Case Rep. 2013;2013:bcr2013010262.CrossRefPubMedPubMedCentral
89.
Metadaten
Titel
Hepatic and Intra-abdominal Tuberculosis: 2016 Update
verfasst von
Richard P. T. Evans
Moustafa Mabrouk Mourad
Lee Dvorkin
Simon R. Bramhall
Publikationsdatum
01.12.2016
Verlag
Springer US
Erschienen in
Current Infectious Disease Reports / Ausgabe 12/2016
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-016-0546-5

Weitere Artikel der Ausgabe 12/2016

Current Infectious Disease Reports 12/2016 Zur Ausgabe

Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

Echinocandin Resistance in Candida Species: a Review of Recent Developments

Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

Antibiotic Resistance in Pediatric Urinary Tract Infections

Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE)

Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

Azole Resistance in Candida glabrata

Central Nervous System Infections (K Bloch, Section Editor)

Update on the Diagnosis and Management of Neurocysticercosis

Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise